UniSuper Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,500
| Closed | -$318K | – | 687 |
|
|
2025
Q1 | $318K | Hold |
4,500
| – | – | ﹤0.01% | 651 |
|
|
2024
Q4 | $296K | Sell |
4,500
-2,889
| -39% | -$190K | ﹤0.01% | 646 |
|
|
2024
Q3 | $519K | Buy |
7,389
+2,889
| +64% | +$203K | ﹤0.01% | 621 |
|
|
2024
Q2 | $370K | Buy |
4,500
+1,800
| +67% | +$148K | ﹤0.01% | 862 |
|
|
2024
Q1 | $236K | Buy |
2,700
+1,400
| +108% | +$122K | ﹤0.01% | 913 |
|
|
2023
Q4 | $125K | Hold |
1,300
| – | – | ﹤0.01% | 623 |
|
|
2023
Q3 | $115K | Hold |
1,300
| – | – | ﹤0.01% | 560 |
|
|
2023
Q2 | $113K | Buy |
+1,300
| New | +$113K | ﹤0.01% | 560 |
|